IPO Calendar
Lead Manager
- J P Morgan Chase (482)
- Goldman Sachs (458)
- Morgan Stanley (413)
- Bank of America Merrill Lynch (354)
- Citigroup (222)
- Jefferies (211)
- Credit Suisse (180)
- Barclays (150)
- Cowen and Company (145)
- Deutsche Bank (81)
- Piper Jaffray (70)
- Leerink Partners (69)
- Stifel (65)
- UBS Investment Bank (52)
- Evercore (51)
- RBC Capital (50)
- BMO Capital (49)
- Wells Fargo (45)
- William Blair (37)
- Raymond James (36)
More +
IPO - Pricing (9)
Evercore
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 7 | Centogene B.V. | Health-Care | 14 | 4 | LRNK | EVCR | 23.2% | -10.8% | |||
| Oct 25 | Phathom Pharmac | Health-Care | 19 | 9 | GS | JEFF | EVCR | 9% | 29.5% | ||
| Oct 25 | Cabaletta Bio I | Health-Care | 11 | 6 | MS | COWN | EVCR | 14.3% | -9.1% | ||
| Oct 25 | Aesthetic Medic | Health-Care | 12 | 2 | MS | COWN | EVCR | 31% | -16.4% | ||
| Oct 17 | Innate Pharma S | Health-Care | 5.5 | 12 | CITI | EVCR | 6.6% | 10% | |||
| Jul 18 | Mirum Pharmaceu | Health-Care | 15 | 5 | CITI | EVCR | GGNH | 29.5% | -11.9% | ||
| Jun 20 | Atreca Inc. | NA | 17 | 7 | COWN | EVCR | Stifel | 34.1% | 6.2% | ||
| Jun 20 | Akero Therapeut | NA | 16 | 5 | JPM | JEFF | EVCR | 51.9% | 14.5% | ||
| Feb 15 | Stealth BioTher | NA | 12 | 6 | JEFF | EVCR | BMO | 17.5% | -0.8% | ||
*
Lead manager or one of top three managers in an underwriting team.